Mechanisms of Action of Mesenchymal Stem Cells in Metabolic-Associated Fatty Liver Disease

Metabolic-associated fatty liver disease (MAFLD) is currently the most common chronic liver disease worldwide. However, its pathophysiological mechanism is complicated, and currently, it has no FDA-approved pharmacological therapies. In recent years, mesenchymal stem cell (MSC) therapy has attracted...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sitong Yi (Auteur), Qingwei Cong (Auteur), Ying Zhu (Auteur), Qiumin Xu (Auteur)
Format: Livre
Publié: Hindawi Limited, 2023-01-01T00:00:00Z.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

Connect to this object online.

3rd Floor Main Library

Informations d'exemplaires de 3rd Floor Main Library
Cote: A1234.567
Exemplaire 1 Disponible